Novel therapeutic targets in primary biliary cirrhosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel therapeutic targets in primary biliary cirrhosis

Published:2015-02-03 Issue:3 Volume:12 Page:147-158
ISSN:1759-5045
Container-title:Nature Reviews Gastroenterology & Hepatology
language:en
Short-container-title:Nat Rev Gastroenterol Hepatol

Author:

Dyson Jessica K.,Hirschfield Gideon M.,Adams David H.,Beuers Ulrich,Mann Derek A.,Lindor Keith D.,Jones David E. J.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/nrgastro.2015.12.pdf

Reference159 articles.

1. Hirschfield, G. M. & Gershwin, M. E. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu. Rev. Pathol. 8, 303–330 (2013).

2. Griffiths, L., Dyson, J. K. & Jones, D. E. The new epidemiology of primary biliary cirrhosis. Semin. Liver Dis. 34, 318–328 (2014).

3. Mells, G. et al. The impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC National Study. Hepatology 58, 273–283 (2013).

4. Carbone, M. et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastorenterology 144, 560–569 (2013).

5. Dyson, J. K. et al. Unmet clinical need in autoimmune liver diseases. J. Hepatol. 62, 208–218 (2014).

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence;Expert Review of Anti-infective Therapy;2024-07-09

2. Another renaissance for bile acid gastrointestinal microbiology;Nature Reviews Gastroenterology & Hepatology;2024-02-21

3. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications;Autoimmunity Reviews;2024-02

4. The protective effect of forsythiaside A on 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver injury in mice: Based on targeted metabolomics and molecular biology technology;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-12

5. Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products;Frontiers in Immunology;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3